Hypertensive pregnancy disorders as a risk factor for future cardiovascular and metabolic disorders (Tehran Lipid and Glucose Study)

Journal of Obstetrics and Gynaecology Research

Volumn 39, Issue 5, 2013, Pages 891-897

  Hashemi, Somayeh ^a   Tehrani, Fahimeh Ramezani ^a   Mehrabi, Yadollah ^b   Azizi, Fereidoun ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes mellitus; Dyslipidemia; Hypertension; Hypertensive pregnancy disorders; Pre eclampsia

Indexed keywords

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROL GROUP; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; NON INSULIN DEPENDENT DIABETES MELLITUS; PREECLAMPSIA; PRIMARY PREVENTION; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

ADULT; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; HYPERTENSION, PREGNANCY-INDUCED; INCIDENCE; IRAN; LIPID METABOLISM DISORDERS; METABOLIC DISEASES; MIDDLE AGED; PREGNANCY; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84880260492     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2012.02069.x     Document Type: Article

References (41)

1. Wilson BJ, Watson MS, Prescott GJ et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: Results from cohort study. BMJ 2003; 326: 845.
2. Redman CW. Immunology of preeclampsia. Semin Perinatol 1991; 15: 257-262.
3. Pabinger I, Vormittag R. Thrombophilia and pregnancy outcomes. J Thromb Haemost 2005; 3: 1603-1610.
4. Sankaralingam S, Arenas IA, Lalu MM, Davidge ST. Preeclampsia: Current understanding of the molecular basis of vascular dysfunction. Expert Rev Mol Med 2006; 8: 1-20.
5. Koopmans CM, Bijlenga D, Groen H et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): A multicentre, open-label randomised controlled trial. Lancet 2009; 374: 979-988.
6. Ness RB, Sibai BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 2006; 195: 40-49.
7. Haukkamaa L, Salminen M, Laivuori H, Leinonen H, Hiilesmaa V, Kaaja R. Risk for subsequent coronary artery disease after preeclampsia. Am J Cardiol 2004; 93: 805-808.
8. Hermes W, Franx A, van Pampus MG et al. 10-year cardiovascular event risks for women who experienced hypertensive disorders in late pregnancy: The HyRAS study. BMC Pregnancy Childbirth 2010; 10: 28.
9. Chesley SC, Annitto JE, Cosgrove RA. The remote prognosis of eclamptic women: Sixth periodic report. Am J Obstet Gynecol 1976; 124: 446-459.
10. Garovic VD, Bailey KR, Boerwinkle E et al. Hypertension in pregnancy as a risk factor for cardiovascular disease later in life. J Hypertens 2010; 28: 826-833.
11. Lindeberg S, Axelsson O, Jorner U, Malmberg L, Sandstrom B. A prospective controlled five-year follow-up study of primiparas with gestational hypertension. Acta Obstet Gynecol Scand 1988; 67: 605-609.
12. Selvaggi L, Loverro G, Schena FP, Manno C, Cagnazzo G. Long term follow-up of women with hypertension in pregnancy. Int J Gynaecol Obstet 1988; 27: 45-49.
13. Lykke JA, Langhoff-Roos J, Sibai BM, Funai EF, Triche EW, Paidas MJ. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 2009; 53: 944-951.
14. Kaaja RJ, Greer IA. Manifestations of chronic disease during pregnancy. JAMA 2005; 294: 2751-2757.
15. Kestenbaum B, Seliger SL, Easterling TR et al. Cardiovascular and thromboembolic events following hypertensive pregnancy. Am J Kidney Dis 2003; 42: 982-989.
16. Funai EF, Friedlander Y, Paltiel O et al. Long-term mortality after preeclampsia. Epidemiology 2005; 16: 206-215.
17. Jonsdottir LS, Arngrimsson R, Geirsson RT, Sigvaldason H, Sigfusson N. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand 1995; 74: 772-776.
18. Rodie VA, Freeman DJ, Sattar N, Greer IA. Pre-eclampsia and cardiovascular disease: Metabolic syndrome of pregnancy?. Atherosclerosis 2004; 175: 189-202.
19. Rodie VA, Caslake MJ, Stewart F et al. Fetal cord plasma lipoprotein status in uncomplicated human pregnancies and in pregnancies complicated by pre-eclampsia and intrauterine growth restriction. Atherosclerosis 2004; 176: 181-187.
20. van Rijn BB, Hoeks LB, Bots ML, Franx A, Bruinse HW. Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia. Am J Obstet Gynecol 2006; 195: 723-728.
21. Han JL. Actions to control hypertension among adults in Oklahoma. Prev Chronic Dis 2011; 8: A10.
22. Mosca L, Linfante AH, Benjamin EJ et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation 2005; 111: 499-510.
23. Azizi F, Rahmani M, Ghanbarian A et al. Serum lipid levels in an Iranian adults population: Tehran Lipid and Glucose Study. Eur J Epidemiol 2003; 18: 311-319.
24. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001; 20: IX-XIV.
25. Chobanian AV, Bakris GL, Black HR et al. The Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. JAMA 2003; 289: 2560-2572.
26. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000; 183: S1-S22.
27. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004; 27: S5-S10.
28. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol inAdult (Adult Treatment Panel III). Third Report of the National Cholesterol Educational Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adult (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-3421.
29. Canti IC, Komlos M, Martins-Costa SH, Ramos JG, Capp E, Corleta HE. Risk factors for cardiovascular disease ten years after preeclampsia. Sao Paulo Med J 2010; 128: 10-13.
30. Fisher KA, Luger A, Spargo BH, Lindheimer MD. Hypertension in pregnancy: Clinical-pathological correlations and remote prognosis. Medicine (Baltimore) 1981; 60: 267-276.
31. Wolf M, Hubel CA, Lam C et al. Preeclampsia and future cardiovascular disease: Potential role of altered angiogenesis and insulin resistance. J Clin Endocrinol Metab 2004; 89: 6239-6243.
32. Seely EW, Solomon CG. Insulin resistance and its potential role in pregnancy-induced hypertension. J Clin Endocrinol Metab 2003; 88: 2393-2398.
33. Callaway LK, Lawlor DA, O'Callaghan M, Williams GM, Najman JM, McIntyre HD. Diabetes mellitus in the 21 years after a pregnancy that was complicated by hypertension: Findings from a prospective cohort study. Am J Obstet Gynecol 2007; 197: 492. e1-7.
34. Zeeman GG, Fleckenstein JL, Twickler DM, Cunningham FG. Cerebral infarction in eclampsia. Am J Obstet Gynecol 2004; 190: 714-720.
35. Craici IM,Wagner SJ, Hayman SR, Garovic VD. Pre-eclamptic pregnancies: An opportunity to identify women at risk for future cardiovascular disease. Womens Health (Lond Engl) 2008; 4: 133-135.
36. Herrmann J, Lerman LO, Mukhopadhyay D, Napoli C, Lerman A. Angiogenesis in atherogenesis. Arterioscler Thromb Vasc Biol 2006; 26: 1948-1957.
37. Forest JC, Girouard J, Masse J et al. Early occurrence of metabolic syndrome after hypertension in pregnancy. Obstet Gynecol 2005; 105: 1373-1380.
38. de Simone G, Devereux RB, Chinali M et al. Risk factors for arterial hypertension in adults with initial optimal blood pressure: The Strong Heart Study. Hypertension 2006; 47: 162-167.
39. Racette SB, Evans EM, Weiss EP, Hagberg JM, Holloszy JO. Abdominal adiposity is a stronger predictor of insulin resistance than fitness among 50-95 year olds. Diabetes Care 2006; 29: 673-678.
40. Klemmensen AK, Olsen SF, Osterdal ML, Tabor A. Validity of preeclampsia-related diagnoses recorded in a national hospital registry and in a postpartum interview of the women. Am J Epidemiol 2007; 166: 117-124.
41. Diehl CL, Brost BC, Hogan MC et al. Preeclampsia as a risk factor for cardiovascular disease later in life: Validation of a preeclampsia questionnaire. Am J Obstet Gynecol 2008; 198: e11-e13.